BPC-157 Nasal Spray
BPC-157 Nasal Spray contains BPC-157, a synthetic 15-amino-acid peptide corresponding to a partial sequence associated with human gastric juice protein BPC and investigated predominantly in preclinical research, and is available from Direct SARMs in 15 ml and 30 ml sizes.
TOP SELLER
99.1% purityBatch COA includedStore 2–8°C
Price range: $24.33 through $42.40
Buy more, save more
7.5% offspend $250.00
12.5% offspend $400.00
Spend $250.00 for 7.5% off on qualifying items · Applied automatically at checkout
Researchers who bought BPC-157 Nasal Spray also bought
BPC-157 Nasal Spray
BPC-157 is a synthetic peptide consisting of 15 amino acids and having the sequence GEPPPGKPADDAGLV; it is derived from a segment of a protein that occurs in human gastric juice. Scientific studies have mainly looked into BPC-157 in preclinical models, such as those involving research on angiogenesis, cellular signalling and various processes related to tissue repair. However, the results obtained from these studies cannot be taken as indicating any clinical effects or outcomes connected with the nasal spray form.
Direct SARMs supplies BPC-157 as a pre-mixed aqueous nasal spray format for laboratory and analytical research. The 15 ml format contains 2 mg of BPC-157, while the 30 ml format contains 4 mg. The nasal spray designation describes the physical presentation of the research material and does not establish intranasal bioavailability, biological activity, safety or suitability for administration.
BPC-157 Nasal Spray is supplied solely as a laboratory research material and is not intended for human or animal consumption or administration, or for diagnostic, therapeutic, clinical or veterinary use.
Benefits of the nasal spray format
1
The dispensing is pre-measured. Each time the spray mechanism is actuated, it releases a constant volume, which allows for repeatable dispensing when carrying out research procedures.
2
Convenient format. Compact spray bottles are straightforward to store, handle, and transport within an appropriate research environment.
3
Ready to use. Unlike lyophilized peptides, which are provided in vials, nasal spray formulations are in liquid form and do not need to be reconstituted before being handled in the laboratory.
4
Protected storage. The bottle protects the formulation by preventing unnecessary handling and exposure to the environment between research procedures.
5
Simple dispensing. The product can be dispensed easily. With an integrated spraying mechanism, it is not necessary to draw the liquid from a vial, offering a simple way to dispense the formulation during research.
Visit the BPC-157 Research Hub ▸
BPC-157 is supplied exclusively for laboratory research use. The information on this page is provided for scientific and educational reference and is based on available published research. This product is not intended for human or veterinary use, diagnosis, treatment, or prevention of any disease or medical condition. It is intended solely for qualified laboratory research and must be handled in accordance with applicable laboratory safety requirements.
Buy BPC-157 Nasal Spray Dubai from Direct SARMS.
Additional information
| Size(s) | 15ml and 30ml |
| Amount Per Nasal | 15ml = 2mg | 30ml = 4mg |
| Purity | 99.1% |
| Molecular Formula | C62H98N16O22 |
| Molecular Weight | 1419.5 g/mol |
| Sequence | GEPPPGKPADDAGLV |
| Physical Form | Pre-mixed aqueous solution |
General information
Applies to all Direct Sarms research compounds unless noted otherwise on the product.
Storage & handling
Store the nasal spray according to the instructions provided on the product label. Keep the bottle securely closed when not in use and protect it from excessive heat and direct light. Follow any product-specific refrigeration requirements stated on the label.
Shipping & discretion
Fully tracked dispatch with worldwide shipping available. Sent in plain, discreet outer packaging with no product description on the label.
FDA disclosure & intended use
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. Research use only — not for human or animal consumption. You must be 18+ and a qualified researcher.
Got a question about this BPC-157 compound?
BPC-157 Nasal Spray is supplied as a pre-mixed aqueous solution, providing the peptide in liquid form rather than as a dry or lyophilised research material.
Direct SARMs supplies BPC-157 Nasal Spray in 15 ml and 30 ml formats. The 15 ml format contains 2 mg of BPC-157, while the 30 ml format contains 4 mg.
The preparation contains BPC-157, a synthetic pentadecapeptide consisting of 15 amino-acid residues with the sequence GEPPPGKPADDAGLV. This sequence is recognised in the scientific literature and FDA substance records for BPC-157.
The main difference is the physical presentation of the research material. BPC-157 Nasal Spray contains the peptide in a pre-mixed liquid solution, whereas lyophilised BPC-157 is supplied as a dry, freeze-dried material. The nasal spray format itself does not establish intranasal bioavailability, biological activity or efficacy.
Certificate of Analysis
| Identity | BPC-157 | CONFORMS |
| Purity (HPLC) | 99.1% | CONFORMS |
| Mass (LC-MS) | 1419.5 g/mol | CONFORMS |
| Appearance | Pre-mixed aqueous solution | CONFORMS |
